Clin2
NCT06999551Possibly a fitNot yet recruiting

Comparing insulin glargine vs NPH insulin in type 2 diabetes

Diabetes Mellitus

Part of Hormones & metabolism clinical trials.

This trial tests if a newer long-acting insulin (glargine) works better than a standard insulin (NPH) for Tunisian patients with type 2 diabetes. You may join if you've been on NPH insulin for 5–10 years and your blood sugar control is moderate.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old
  • You have type 2 diabetes and have been using NPH insulin for 5 to 10 years
  • You take two doses of NPH insulin daily and your insulin and diabetes pills have been the same for at least 2 months
  • Your latest HbA1c (average blood sugar) is between 7% and 10%
  • You are willing to use a continuous glucose monitor and check your blood sugar with a meter
  • You are not pregnant or breastfeeding, and you do not have serious eye disease from diabetes

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06925334Enrolling by invitation· Phase 4
Comparing a new insulin combo with premixed insulin for type 2 diabetes

This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.

Beijing, Beijing Municipality
NCT03087032Recruiting· Phase 4
Liraglutide injections vs insulin for uncontrolled type 2 diabetes

This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.

Xiamen, Fujian
NCT07146347Recruiting· Phase 1
Comparing a new long-acting insulin for type 2 diabetes

This study tests a new once-daily insulin (GZR4) against an approved insulin (degludec) in people with type 2 diabetes to see how well it controls blood sugar. You may qualify if you are already using a stable dose of background insulin.

Neuss
NCT06246799Recruiting· Phase 3
Comparing two pill combinations for new diabetes

This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.

San Antonio, Texas
NCT06619301Recruiting· Phase 3
Insulin options for diabetes in pregnancy

This trial compares two types of insulin (glargine and NPH) to see which works better for managing blood sugar in pregnant women with gestational diabetes or type 2 diabetes. If you need to start insulin during pregnancy, you may be able to join.

Maywood, Illinois
NCT07173712Not yet recruiting· Phase 4
Switching diabetes treatment after short-term intensive insulin

This study tests how well different diabetes medications work after a brief period of intensive insulin therapy. It may help you find a simpler, effective treatment plan tailored to your needs.

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.